Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of intramuscular DTaP vaccination at different injection sites in healthy infants
CTR20241070Phase 4Active
- Sponsor
- Beijing Minhai Biological
- Start
- Apr 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of diphtheria + tetanus + pertussis (acellular, component) vaccine (adsorbed) in pertussis, diphtheria, Tetanus, sponsored by Beijing Minhai Biological. Started Apr 2024; status: active.
02
Drugs
diphtheria + tetanus + pertussis (acellular, component) vaccine (adsorbed)
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on CTR20241070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241070.